Show simple item record

Alirocumab-Associated Lichenoid Reaction: A Case Report

dc.contributor.authorRomán Cheuque, R.
dc.contributor.authorNavarro Navarro, Irene
dc.contributor.authorJiménez Gallo, D.
dc.contributor.authorLinares Barrios, Mario Dionisio 
dc.contributor.otherMedicinaes_ES
dc.date.accessioned2024-10-29T07:45:09Z
dc.date.available2024-10-29T07:45:09Z
dc.date.issued2024
dc.identifier.issn0001-7310
dc.identifier.issn1578-2190
dc.identifier.urihttp://hdl.handle.net/10498/33757
dc.description.abstractLichenoid eruptions (LE) pose a real diagnostic challenge dueto their clinical and histopathological similarity to lichenplanus. Inducers are varied being drug-induced lichenoideruption (DILE) a common entity, particularly in an eracharacterized by the emergence of biologic or targeted ther-apies. This is the case of an alirocumab-induced lichenoideruption, a proprotein convertase subtilisin/kexin type 9(PCSK-9) inhibitor used to treat dyslipidemia, a drug rarelyassociated with local skin adverse reactions and exception-ally with urticaria, or vasculitis.es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourceActas Dermo-Sifiliograficas - 2024, Vol. 115 n.5 pp. 522-523es_ES
dc.subjectAlirocumabes_ES
dc.subjectlichenoid eruptiones_ES
dc.titleAlirocumab-Associated Lichenoid Reaction: A Case Reportes_ES
dc.title.alternativeErupción liquenoide asociada al uso de alirocumab: presentación de un casoes_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1016/J.AD.2022.11.022
dc.type.hasVersionVoRes_ES


Files in this item

Name:
OA_2024_0729.pdf
Size:
1.007Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
This work is under a Creative Commons License Attribution-NonCommercial-NoDerivatives 4.0 Internacional